Optimizing the clinical utility of PCA3 to diagnose prostate cancer in initial prostate biopsy.

Background: PCA3 has been included in a nomogram outperforming previous clinical models for the prediction of any prostate cancer (PCa) and high grade PCa (HGPCa) at the initial prostate biopsy (IBx). Our objective is to validate such IBx-specific PCA3-based nomogram. We also aim to optimize the use...

Full description

Bibliographic Details

Published in:	BMC Cancer Vol. 15; no. 1; pp. 1 - 9
Main Authors:	Rubio-Briones, Jose, Borque, Angel, Esteban, Luis M., Casanova, Juan, Fernandez-Serra, Antonio, Rubio, Luis, Casanova-Salas, Irene, Sanz, Gerardo, Domínguez-Escrig, Jose, Collado, Argimiro, Gómez-Ferrer, Alvaro, Iborra, Inmaculada, Ramírez-Backhaus, Miguel, Martínez, Francisco, Calatrava, Ana, Lopez-Guerrero, Jose A.
Format:	research tables/charts Journal Article
Published:	BioMed Central 9/12/2015
Online Access:	View this record in EBSCOhost